Improving diabetes management through a shared care model
The Effect of Share Care Model in the Improvement of Diabetes Management
Beijing Tsinghua Chang Gung Hospital · NCT03707379
This study is testing a new way to manage diabetes in China by using a team of experts and technology to see if it helps people with Type 2 diabetes do better than traditional care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3500 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Beijing Tsinghua Chang Gung Hospital (other) |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT03707379 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance diabetes management in China by implementing a localized share care model, originally developed in Taiwan. It involves collaboration between diabetic experts, educators, and community doctors using an interactive information platform and mobile applications for self-monitoring. The study will compare the outcomes of patients managed under this new model against those receiving conventional care across six diabetic centers over a five-year period. The goal is to assess the effectiveness of this innovative approach in achieving better health outcomes for Type 2 diabetes patients.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with Type 2 diabetes.
Not a fit: Patients with severe heart failure, hepatic failure, or renal failure may not benefit from this study.
Why it matters
Potential benefit: If successful, this model could significantly improve diabetes management and patient outcomes in China.
How similar studies have performed: While this approach is innovative for the region, similar models have shown promise in other contexts, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Type 2 diabetic patients Exclusion Criteria: * Patients had not signed the consent form * Patients with sever hart failure, hepatic failure, renal failure
Where this trial is running
Beijing, Beijing Municipality
- Beijing Ruijing Diabetes Hospital — Beijing, Beijing Municipality, China (RECRUITING)
Study contacts
- Study coordinator: Jianzhong Xiao, PHD
- Email: Xiaojzh858@sina.com
- Phone: 86-13683685711
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes Mellitus, Type 2, Diabetes mellitus, Diabetic management, Share care